Funded projects

  • Ebl/009/21 - Pinpointing distinct rhodocytin suprastructures and novel CLEC-2 targeting toxins to curb podoplanin-mediated platelet assistance of hematogenous metastasis
    Principal Investigator: Johannes Eble
    Funding period: 01/21 - 12/23
  • Lud/013/21 - Exploiting synergistic anti-cancer efficacy by combining oncolytic viruses and CAR Tcells to target lung cancer
    Principal Investigator: Stephan Ludwig
    Funding period: 01/21 - 12/23
  • Mik/015/21 - Investigation of the role of the Armadillo repeat-containing X-linked Protein (ARMCX)family in normal hematopoiesis and acute myeloid leukemia
    Principal Investigator: Jan-Henrik Mikesch
    Funding period: 01/21 - 12/23
  • Kr/031/21 - Characterization of new substrates of the tumor suppressor LKB1 in thepathogenesis of cancer
    Principal Investigator: Michael Krahn
    Funding period: 01/21 - 12/23